Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
January-2019 Volume 43 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2019 Volume 43 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR

  • Authors:
    • Yu Ding
    • Zhaochang Jiang
    • Bohou Xia
    • Lizong Zhang
    • Caijuan Zhang
    • Jianhang Leng
  • View Affiliations / Copyright

    Affiliations: Central Laboratory, Hangzhou First People's Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310006, P.R. China, Department of Pathology, Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310006, P.R. China, Department of Pharmacy, Hunan Chinese Medical University, Changsha, Hunan 410208, P.R. China, Department of Experimental Animal Center, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China, Department of Gynecological and Obstetrics, Hangzhou First People's Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang 310006, P.R. China
    Copyright: © Ding et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 316-324
    |
    Published online on: November 5, 2018
       https://doi.org/10.3892/ijmm.2018.3977
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder with unknown etiology and unsatisfactory clinical treatment. Considering the ethical limitations of studies involving humans, animal models that reflect features of PCOS and insulin resistance (IR) are crucial resources in investigating this syndrome. Our previous study showed that mitochondrial dysfunction resulted from pathogenic mutations of mitochondrial DNA (mtDNA), and that oxidative stress had an active role in the phenotypic manifestation of PCOS‑IR. Therefore, it was hypothesized that limiting oxidative stress and mitochondrial damage may be useful and effective for the clinical treatment of PCOS‑IR. For this purpose, the present study examined the therapeutic effects of the mitochondria‑targeted antioxidant MitoQ10 for PCOS‑IR. Furthermore, the histopathology was used to analysis the ovarian morphological changes. The endocrine and reproductive related parameters were analyzed by ELISA approach. A PCOS‑IR model was successfully established by subcutaneous injection of rats with testosterone propionate and feeding a high‑fat diet. The 30 female Sprague‑Dawley rats were then divided into three groups, comprising a control (n=10), animal model (PCOS‑IR, n=10) and MitoQ10 treatment (n=10) group. It was found that MitoQ10 significantly improved the IR condition and reversed the endocrine and reproductive conditions of PCOS. In addition, the impaired mitochondrial functions were improved following MitoQ10 administration. Notably, western blot results suggested that this antioxidant reduced the expression levels of apoptosis‑related proteins cytochrome c and B‑cell lymphoma‑2 (Bcl‑2)‑associated X protein, whereas the anti‑apoptotic protein Bcl‑extra large was increased following MitoQ10 treatment. Taken together, the data indicated that the MitoQ10 may have a beneficial favorable therapeutic effect on animals with PCOS‑IR, most likely via the protection of mitochondrial functions and regulation of programmed cell death‑related proteins.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

McCartney CR and Marshall JC: Clinical Practice. Clinical practice. Polycystic ovary syndrome. N Engl J Med. 375:54–64. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Ali AT: Polycystic ovary syndrome and metabolic syndrome. Ceska Gynekol. 80:279–289. 2015.PubMed/NCBI

3 

Kalyanaraman B: Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biol. 1:244–257. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Liu X, Zhu Q, Zhang M, Yin T, Xu R, Xiao W, Wu J, Deng B, Gao X, Gong W, et al: Isoliquiritigenin ameliorates acute pancreatitis in mice via inhibition of oxidative stress and modulation of the Nrf2/HO-1 pathway. Oxid Med Cell Longev. 2018.7161592:2018.

5 

Dalle-Donne I, Rossi R, Colombo R, Giustarini D and Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem. 52:601–623. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Escobar-Morreale HF, Luque-Ramírez M and San Millán JL: The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 26:251–282. 2005. View Article : Google Scholar

7 

Zuo T, Zhu M and Xu W: Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016.8589318:2016.

8 

Picard M, Wallace DC and Burelle Y: The rise of mitochondria in medicine. Mitochondrion. 30:105–116. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Böttger EC and Schacht J: The mitochondrion: A perpetrator of acquired hearing loss. Hear Res. 303:12–19. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Ding Y, Xia BH, Zhang CJ and Zhuo GC: Mitochondrial tRNALeu(UUR) C3275T, tRNAGln T4363C and tRNALys A8343G mutations may be associated with PCOS and metabolic syndrome. Gene. 642:299–306. 2018. View Article : Google Scholar

11 

Ding Y, Xia BH, Zhang CJ and Zhuo GC: Mutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndrome. Am J Transl Res. 9:2984–2996. 2017.PubMed/NCBI

12 

Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA and Murphy MP: Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem. 276:4588–4596. 2001. View Article : Google Scholar

13 

Smith RA and Murphy MP: Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann NY Acad Sci. 1201:96–103. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B and Reddy PH: Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer’s disease neurons. J Alzheimers Dis. 20(Suppl 2): S609–S631. 2010. View Article : Google Scholar

15 

Mao P, Manczak M, Shirendeb UP and Reddy PH: MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Biochim Biophys Acta. 1832.2322–2331. 2013.

16 

Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cochemé HM, Murphy MP and Dominiczak AF: Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension. 54:322–328. 2009. View Article : Google Scholar : PubMed/NCBI

17 

McLachlan J, Beattie E, Murphy MP, Koh-Tan CH, Olson E, Beattie W, Dominiczak AF, Nicklin SA and Graham D: Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function. J Hypertens. 32:555–564. 2014. View Article : Google Scholar :

18 

Keskin M, Kurtoglu S, Kendirci M, Atabek ME and Yazici C: Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 115:e500–e503. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Yarian CS, Toroser D and Sohal RS: Aconitase is the main functional target of aging in the citric acid cycle of kidney mitochondria from mice. Mech Ageing Dev. 127:79–84. 2006. View Article : Google Scholar

20 

Yuan Y, Chen Y, Zhang P, Huang S, Zhu C, Ding G, Liu B, Yang T and Zhang A: Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. Free Radic Biol Med. 53:30–43. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Raza H, John A and Howarth FC: Increased oxidative stress and mitochondrial dysfunction in zucker diabetic rat liver and brain. Cell Physiol Biochem. 35:1241–1251. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Dignam JD, Lebovitz RM and Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489. 1983. View Article : Google Scholar : PubMed/NCBI

23 

Victor VM, Rovira-Llopis S, Bañuls C, Diaz-Morales N, Martinez de Marañon A, Rios-Navarro C, Alvarez A, Gomez M, Rocha M and Hernández-Mijares A: Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: Role of myeloperoxidase. PLoS One. 11:e015–1960. 2016. View Article : Google Scholar

24 

Serrano Mujica L, Bridi A, Della Méa R, Rissi VB, Guarda N, Moresco RN, Premaor MO, Antoniazzi AQ, Gonçalves PBD and Comim FV: Oxidative stress and metabolic markers in pre- and postnatal polycystic ovary syndrome rat protocols. J Inflamm Res. 11:193–202. 2018. View Article : Google Scholar : PubMed/NCBI

25 

Ross MF, Kelso GF, Blaikie FH, James AM, Cochemé HM, Filipovska A, Da Ros T, Hurd TR, Smith RA and Murphy MP: Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Mosc). 70:222–230. 2005. View Article : Google Scholar

26 

Firsov AM, Kotova EA, Orlov VN, Antonenko YN and Skulachev VP: A mitochondria-targeted antioxidant can inhibit peroxidase activity of cytochrome c by detachment of the protein from liposomes. FEBS Lett. 590:2836–2843. 2016. View Article : Google Scholar : PubMed/NCBI

27 

James AM, Cochemé HM and Murphy MP: Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing. Mech Ageing Dev. 126:982–986. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Yilmaz N, Inal HA, Gorkem U, Sargin Oruc A, Yilmaz S and Turkkani A: Follicular fluid total antioxidant capacity levels in PCOS. J Obstet Gynaecol. 36:654–657. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Abu Bakar MH, Sarmidi MR, Tan JS and Mohamad Rosdi MN: Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes. Eur J Pharmacol. 799:73–83. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Hafizi Abu Bakar M, Kian Kai C, Wan Hassan WN, Sarmidi MR, Yaakob H and Zaman Huri H: Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: The roles of long chain fatty acids. Diabetes Metab Res Rev. 31:453–475. 2015. View Article : Google Scholar

31 

Yan Y, Su X, Liang Y, Zhang J, Shi C, Lu Y, Gu L and Fu L: Emodin azide methyl anthraquinone derivative triggers mitochondrial-dependent cell apoptosis involving in caspase-8-mediated Bid cleavage. Mol Cancer Ther. 7:1688–1697. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Wang XH, Jia DZ, Liang YJ, Yan SL, Ding Y, Chen LM, Shi Z, Zeng MS, Liu GF and Fu LW: Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway. Cancer Lett. 249:256–270. 2007. View Article : Google Scholar

33 

Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI

34 

Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI

35 

Nechushtan A, Smith CL, Lamensdorf I, Yoon SH and Youle RJ: Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J Cell Biol. 153:1265–1276. 2001. View Article : Google Scholar : PubMed/NCBI

36 

Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, et al: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441–446. 1999. View Article : Google Scholar : PubMed/NCBI

37 

Zhang JY, Yi T, Liu J, Zhao ZZ and Chen HB: Quercetin induces apoptosis via the mitochondrial pathway in KB and KBv200 cells. J Agric Food Chem. 61:2188–2195. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Westphal D, Dewson G, Czabotar PE and Kluck RM: Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta. 1813.521–531. 2011.

39 

Hampton MB and Orrenius S: Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett. 414:552–556. 1997. View Article : Google Scholar : PubMed/NCBI

40 

Eleftheriadis T, Pissas G, Liakopoulos V and Stefanidis I: Cytochrome c as a potentially clinical useful marker of mitochondrial and cellular damage. Front Immunol. 7:2792016. View Article : Google Scholar : PubMed/NCBI

41 

Li H, Huang Y, Chen C, Xiao A, Hou G, Huang Y, Feng X and Guan BO: Real-time cellular cytochrome c monitoring through an optical microfiber: Enabled by a silver-decorated graphene nanointerface. Adv Sci (Weinh). 5:17010742018. View Article : Google Scholar

42 

Radhakrishnan J, Origenes R, Littlejohn G, Nikolich S, Choi E, Smite S, Lamoureux L, Baetiong A, Shah M and Gazmuri RJ: Plasma cytochrome c detection using a highly sensitive electrochemiluminescence enzyme-linked immunosorbent assay. Biomark Insights. 12:11772719177469722017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ding Y, Jiang Z, Xia B, Zhang L, Zhang C and Leng J: Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. Int J Mol Med 43: 316-324, 2019.
APA
Ding, Y., Jiang, Z., Xia, B., Zhang, L., Zhang, C., & Leng, J. (2019). Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. International Journal of Molecular Medicine, 43, 316-324. https://doi.org/10.3892/ijmm.2018.3977
MLA
Ding, Y., Jiang, Z., Xia, B., Zhang, L., Zhang, C., Leng, J."Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR". International Journal of Molecular Medicine 43.1 (2019): 316-324.
Chicago
Ding, Y., Jiang, Z., Xia, B., Zhang, L., Zhang, C., Leng, J."Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR". International Journal of Molecular Medicine 43, no. 1 (2019): 316-324. https://doi.org/10.3892/ijmm.2018.3977
Copy and paste a formatted citation
x
Spandidos Publications style
Ding Y, Jiang Z, Xia B, Zhang L, Zhang C and Leng J: Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. Int J Mol Med 43: 316-324, 2019.
APA
Ding, Y., Jiang, Z., Xia, B., Zhang, L., Zhang, C., & Leng, J. (2019). Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR. International Journal of Molecular Medicine, 43, 316-324. https://doi.org/10.3892/ijmm.2018.3977
MLA
Ding, Y., Jiang, Z., Xia, B., Zhang, L., Zhang, C., Leng, J."Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR". International Journal of Molecular Medicine 43.1 (2019): 316-324.
Chicago
Ding, Y., Jiang, Z., Xia, B., Zhang, L., Zhang, C., Leng, J."Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR". International Journal of Molecular Medicine 43, no. 1 (2019): 316-324. https://doi.org/10.3892/ijmm.2018.3977
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team